北京美科美生物公司代理nutrapharma

Pharmaceuticals

OTC Homeopathics


Nutra Pharma致力于通过开发和收购创新的制药和生命科学解决方案，为患者、客户、投资者和商业伙伴带来成功，这些解决方案将改善全世界人民的生活。

Nutra Pharma Corp.（OTC:NPHC）Nutra Pharma Corporation是一家生物技术公司，专门从事医药产品和技术的收购、许可和商业化，以管理神经系统疾病、癌症、自身免疫和传染病，包括多发性硬化症（MS），人类免疫缺陷病毒（HIV）、肾上腺髓质神经病（AMN）和疼痛。此外，该公司还以Nyloxin®和Pet pain Away品牌销售用于治疗疼痛的药品™.
Nutra Pharma is dedicated to the success of its patients, customers, investors and business partners through its development and acquisition of innovative pharmaceutical and life science solutions that will improve the lives of people throughout the world.

Nutra Pharma Corp. (OTC: NPHC) Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets drug products for sale for the treatment of pain under the brand Nyloxin® and Pet Pain-Away™.